Skip to main content
Top
Published in: Diabetologia 9/2009

01-09-2009 | Article

Familial association between type 1 diabetes and other autoimmune and related diseases

Authors: K. Hemminki, X. Li, J. Sundquist, K. Sundquist

Published in: Diabetologia | Issue 9/2009

Login to get access

Abstract

Aims/hypothesis

In the era of genome-wide association studies, familial risks are used to estimate disease heritability and success in gene identification. We wanted to estimate associations between type 1 diabetes mellitus and 33 autoimmune and related diseases in parents, offspring, singleton siblings and twins.

Methods

The availability of a Multigeneration Register in Sweden provides reliable access to families throughout the last century. The diseases in individual family members were obtained through linkage to the Hospital Discharge Register. Standardised incidence ratios (SIRs) were calculated as relative risks of contracting type 1 diabetes in family members of affected patients compared with those lacking affected family members.

Results

Among a total of 450,899 patients, 21,168 were diagnosed with type 1 diabetes. Familial cases amounted to 10.3% of all type 1 diabetes patients. SIR for type 1 diabetes was 8.23 in offspring of affected parents, 11.92 in singleton siblings, 39.22 in multiplex families and 21.88 in twins; the calculated risk for monozygotic twins was 32.33. Type 1 diabetes in offspring was associated with 13 diseases in parents, including Addison’s disease (SIR 2.41), asthma (1.38), coeliac disease (2.73), Graves’ disease/hyperthyroidism (1.86), Hashimoto disease/hypothyroidism (2.35), pernicious anaemia (3.09), primary biliary cirrhosis (3.63), rheumatoid arthritis (2.12), sarcoidosis (1.62), systemic lupus erythematosus (2.04), ulcerative colitis (1.23) and Wegener’s granulomatosis (2.12).

Conclusions/interpretation

The concordant familial risks for type 1 diabetes were high and the calculated risk for multiplex families and monozygotic twins may be explained by epistatic gene × gene or gene × environment interactions. Familial associations with several autoimmune and related diseases suggest genetic sharing and challenge to gene identification.
Literature
1.
go back to reference Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK (2005) Environmental triggers and determinants of type 1 diabetes. Diabetes 54(Suppl 2):S125–S136PubMedCrossRef Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK (2005) Environmental triggers and determinants of type 1 diabetes. Diabetes 54(Suppl 2):S125–S136PubMedCrossRef
2.
go back to reference Soltesz G, Patterson CC, Dahlquist G (2007) Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology? Pediatr Diabetes 8(Suppl 6):6–14PubMedCrossRef Soltesz G, Patterson CC, Dahlquist G (2007) Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology? Pediatr Diabetes 8(Suppl 6):6–14PubMedCrossRef
3.
go back to reference Hjern A, Soderstrom U (2008) Parental country of birth is a major determinant of childhood type 1 diabetes in Sweden. Pediatr Diabetes 9:35–39PubMed Hjern A, Soderstrom U (2008) Parental country of birth is a major determinant of childhood type 1 diabetes in Sweden. Pediatr Diabetes 9:35–39PubMed
4.
go back to reference Field LL (2002) Genetic linkage and association studies of type 1 diabetes: challenges and rewards. Diabetologia 45:21–35PubMedCrossRef Field LL (2002) Genetic linkage and association studies of type 1 diabetes: challenges and rewards. Diabetologia 45:21–35PubMedCrossRef
5.
go back to reference Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052–1055PubMedCrossRef Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J (2003) Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052–1055PubMedCrossRef
7.
go back to reference Gillespie KM, Gale EA, Bingley PJ (2002) High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 51:210–214PubMedCrossRef Gillespie KM, Gale EA, Bingley PJ (2002) High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 51:210–214PubMedCrossRef
8.
go back to reference Lambert AP, Gillespie KM, Thomson G et al (2004) Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89:4037–4043PubMedCrossRef Lambert AP, Gillespie KM, Thomson G et al (2004) Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89:4037–4043PubMedCrossRef
9.
go back to reference Harjutsalo V, Podar T, Tuomilehto J (2005) Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes 54:563–569PubMedCrossRef Harjutsalo V, Podar T, Tuomilehto J (2005) Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients. Diabetes 54:563–569PubMedCrossRef
10.
go back to reference Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y (2008) Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29:697–725PubMedCrossRef Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y (2008) Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29:697–725PubMedCrossRef
11.
go back to reference The Wellcome Trust Case–Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–683CrossRef The Wellcome Trust Case–Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3, 000 shared controls. Nature 447:661–683CrossRef
12.
go back to reference Ounissi-Benkalha H, Polychronakos C (2008) The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med 14:268–275PubMedCrossRef Ounissi-Benkalha H, Polychronakos C (2008) The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. Trends Mol Med 14:268–275PubMedCrossRef
13.
go back to reference Cooper JD, Smyth DJ, Smiles AM et al (2008) Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 40:1399–1401PubMedCrossRef Cooper JD, Smyth DJ, Smiles AM et al (2008) Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet 40:1399–1401PubMedCrossRef
14.
go back to reference Zhernakova A, van Diemen CC, Wijmenga C (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10:43–55PubMedCrossRef Zhernakova A, van Diemen CC, Wijmenga C (2009) Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 10:43–55PubMedCrossRef
15.
go back to reference Todd JA, Walker NM, Cooper JD et al (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857–864PubMedCrossRef Todd JA, Walker NM, Cooper JD et al (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857–864PubMedCrossRef
16.
go back to reference Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA (2000) Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123:1102–1111PubMedCrossRef Broadley SA, Deans J, Sawcer SJ, Clayton D, Compston DA (2000) Autoimmune disease in first-degree relatives of patients with multiple sclerosis. A UK survey. Brain 123:1102–1111PubMedCrossRef
17.
go back to reference Cho JH, Weaver C (2007) The genetics of inflammatory bowel disease. Gastroenterology 133:1327–1339PubMedCrossRef Cho JH, Weaver C (2007) The genetics of inflammatory bowel disease. Gastroenterology 133:1327–1339PubMedCrossRef
18.
go back to reference Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40:955–962PubMedCrossRef Barrett JC, Hansoul S, Nicolae DL et al (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40:955–962PubMedCrossRef
19.
go back to reference Criswell LA, Pfeiffer KA, Lum RF et al (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561–571PubMedCrossRef Criswell LA, Pfeiffer KA, Lum RF et al (2005) Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 76:561–571PubMedCrossRef
20.
go back to reference Fisher SA, Tremelling M, Anderson CA et al (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet 40:710–712PubMedCrossRef Fisher SA, Tremelling M, Anderson CA et al (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn’s disease. Nat Genet 40:710–712PubMedCrossRef
21.
go back to reference Ludvigsson JF, Ludvigsson J, Ekbom A, Montgomery SM (2006) Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 29:2483–2488PubMedCrossRef Ludvigsson JF, Ludvigsson J, Ekbom A, Montgomery SM (2006) Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 29:2483–2488PubMedCrossRef
22.
go back to reference Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF (2008) Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 93:3915–3921PubMedCrossRef Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF (2008) Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 93:3915–3921PubMedCrossRef
23.
go back to reference Hemminki K, Bermejo JL, Forsti A (2008) Genetics of inflammatory bowel disease: population aspects. Gastroenterology 134:2190–2191PubMedCrossRef Hemminki K, Bermejo JL, Forsti A (2008) Genetics of inflammatory bowel disease: population aspects. Gastroenterology 134:2190–2191PubMedCrossRef
24.
go back to reference Forabosco P, Bouzigon E, Ng MY et al (2009) Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet 17:236–243PubMedCrossRef Forabosco P, Bouzigon E, Ng MY et al (2009) Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet 17:236–243PubMedCrossRef
25.
26.
go back to reference Dorman JS, Steenkiste AR, O’Leary LA, McCarthy BJ, Lorenzen T, Foley TP (2000) Type 1 diabetes in offspring of parents with type 1 diabetes: the tip of an autoimmune iceberg? Pediatr Diabetes 1:17–22PubMedCrossRef Dorman JS, Steenkiste AR, O’Leary LA, McCarthy BJ, Lorenzen T, Foley TP (2000) Type 1 diabetes in offspring of parents with type 1 diabetes: the tip of an autoimmune iceberg? Pediatr Diabetes 1:17–22PubMedCrossRef
27.
go back to reference Nielsen NM, Westergaard T, Frisch M et al (2006) Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. Arch Neurol 63:1001–1004PubMedCrossRef Nielsen NM, Westergaard T, Frisch M et al (2006) Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. Arch Neurol 63:1001–1004PubMedCrossRef
28.
go back to reference Betterle C, Zanchetta R (2003) Update on autoimmune polyendocrine syndromes (APS). Acta Biomed 74:9–33PubMed Betterle C, Zanchetta R (2003) Update on autoimmune polyendocrine syndromes (APS). Acta Biomed 74:9–33PubMed
29.
go back to reference Landgren O, Engels EA, Pfeiffer RM et al (2006) Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case–control study in Scandinavia. J Natl Cancer Inst 98:1321–1330PubMedCrossRef Landgren O, Engels EA, Pfeiffer RM et al (2006) Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case–control study in Scandinavia. J Natl Cancer Inst 98:1321–1330PubMedCrossRef
30.
go back to reference Hemminki K, Li X, Sundquist K, Sundquist J (2008) Familial risks for common diseases: etiologic clues and guidance to gene identification. Mutat Res Rev 658:247–258 Hemminki K, Li X, Sundquist K, Sundquist J (2008) Familial risks for common diseases: etiologic clues and guidance to gene identification. Mutat Res Rev 658:247–258
31.
go back to reference Sundquist K, Martinéus J, Li X, Hemminki K, Sundquist J (2008) Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalisations in Sweden between 1973 and 2004. Rheumatology (Oxford) 47:1199–1202CrossRef Sundquist K, Martinéus J, Li X, Hemminki K, Sundquist J (2008) Concordant and discordant associations between rheumatoid arthritis, systemic lupus erythematosus and ankylosing spondylitis based on all hospitalisations in Sweden between 1973 and 2004. Rheumatology (Oxford) 47:1199–1202CrossRef
32.
go back to reference Hemminki K, Li X, Sundquist J, Sundquist K (2009) Familial associations of rheumatoid arthritis with autoimmune disorders and related conditions. Arthritis Rheum 60:661–668PubMedCrossRef Hemminki K, Li X, Sundquist J, Sundquist K (2009) Familial associations of rheumatoid arthritis with autoimmune disorders and related conditions. Arthritis Rheum 60:661–668PubMedCrossRef
33.
go back to reference Hemminki K, Vaittinen P (1997) Familial cancer in Sweden: population-based study. Int J Oncol 11:273–280 Hemminki K, Vaittinen P (1997) Familial cancer in Sweden: population-based study. Int J Oncol 11:273–280
34.
go back to reference Hemminki K, Li X, Plna K, Granström C, Vaittinen P (2001) The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 40:772–777PubMedCrossRef Hemminki K, Li X, Plna K, Granström C, Vaittinen P (2001) The nation-wide Swedish Family-Cancer Database: updated structure and familial rates. Acta Oncol 40:772–777PubMedCrossRef
35.
go back to reference Gafvels C, Borjesson B, Lithner F (1991) The social consequences of insulin-treated diabetes mellitus in patients 20–50 years of age. An epidemiological case–control study. Scand J Soc Med 19:86–93PubMed Gafvels C, Borjesson B, Lithner F (1991) The social consequences of insulin-treated diabetes mellitus in patients 20–50 years of age. An epidemiological case–control study. Scand J Soc Med 19:86–93PubMed
36.
go back to reference Hemminki K, Vaittinen P, Dong C, Easton D (2001) Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 84:388–391PubMedCrossRef Hemminki K, Vaittinen P, Dong C, Easton D (2001) Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 84:388–391PubMedCrossRef
37.
go back to reference Vogel F, Motulsky A (1996) Human genetics: problems and approaches. Springer, Heidelberg Vogel F, Motulsky A (1996) Human genetics: problems and approaches. Springer, Heidelberg
38.
go back to reference Hemminki K, Li X, Sundquist K, Sundquist J (2007) Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy 37:1320–1325PubMedCrossRef Hemminki K, Li X, Sundquist K, Sundquist J (2007) Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy 37:1320–1325PubMedCrossRef
41.
go back to reference Barrett T (2007) Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered? Pediatr Diabetes Suppl 6:15–23CrossRef Barrett T (2007) Differential diagnosis of type 1 diabetes: which genetic syndromes need to be considered? Pediatr Diabetes Suppl 6:15–23CrossRef
42.
go back to reference Askling J, Brandt L, Lapidus A et al (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54:617–622PubMedCrossRef Askling J, Brandt L, Lapidus A et al (2005) Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut 54:617–622PubMedCrossRef
43.
go back to reference Askling J, Fored CM, Geborek P et al (2006) Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 65:707–712PubMedCrossRef Askling J, Fored CM, Geborek P et al (2006) Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 65:707–712PubMedCrossRef
44.
go back to reference Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J (2005) Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 54:54–59PubMedCrossRef Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J (2005) Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 54:54–59PubMedCrossRef
45.
go back to reference Knight A, Ekbom A, Brandt L, Askling J (2006) Increasing incidence of Wegener’s granulomatosis in Sweden, 1975–2001. J Rheumatol 33:2060–2063PubMed Knight A, Ekbom A, Brandt L, Askling J (2006) Increasing incidence of Wegener’s granulomatosis in Sweden, 1975–2001. J Rheumatol 33:2060–2063PubMed
46.
go back to reference Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K (2009) Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics 10:5–11PubMedCrossRef Hemminki K, Li X, Sundquist J, Hillert J, Sundquist K (2009) Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics 10:5–11PubMedCrossRef
47.
go back to reference Risch N (2001) The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 10:733–741PubMed Risch N (2001) The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 10:733–741PubMed
48.
go back to reference Hemminki K, Lorenzo Bermejo J (2007) Constraints for genetic association studies imposed by attributable fraction and familial risk. Carcinogenesis 28:648–656PubMedCrossRef Hemminki K, Lorenzo Bermejo J (2007) Constraints for genetic association studies imposed by attributable fraction and familial risk. Carcinogenesis 28:648–656PubMedCrossRef
49.
go back to reference Wang WY, Todd JA (2003) The usefulness of different density SNP maps for disease association studies of common variants. Hum Mol Genet 12:3145–3149PubMedCrossRef Wang WY, Todd JA (2003) The usefulness of different density SNP maps for disease association studies of common variants. Hum Mol Genet 12:3145–3149PubMedCrossRef
50.
go back to reference Hemminki K, Forsti A, Lorenzo Bermejo J (2008) The ‘common disease-common variant’ hypothesis and familial risk. PLoS ONE 3:e2504PubMedCrossRef Hemminki K, Forsti A, Lorenzo Bermejo J (2008) The ‘common disease-common variant’ hypothesis and familial risk. PLoS ONE 3:e2504PubMedCrossRef
Metadata
Title
Familial association between type 1 diabetes and other autoimmune and related diseases
Authors
K. Hemminki
X. Li
J. Sundquist
K. Sundquist
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1427-3

Other articles of this Issue 9/2009

Diabetologia 9/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.